Patent details

Basic Information

Publication number:

EP2605788

PCT Application Number:

US2011047762

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP118186196

PCT Publication Number:

WO2012024223

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY WITH ANTI-CD74 ANTIBODIES PROVIDES ENHANCED TOXICITY TO MALIGNANCIES, AUTOIMMUNE DISEASE AND OTHER DISEASES

French Title of Invention:

POLYTHÉRAPIE AVEC DES ANTICORPS ANTI-CD74 PROCURANT UNE TOXICITÉ AMPLIFIÉE POUR LES MALIGNITÉS, LES MALADIES AUTO-IMMUNES ET D'AUTRES MALADIES

German Title of Invention:

KOMBINATIONSTHERAPIE MIT ANTI-CD74-ANTIKÖRPERN FÜR VERSTÄRKTE TOXIZITÄT GEGEN MALIGNOME SOWIE AUTOIMMUN- UND ANDERE KRANKHEITEN

SPC Number:

Dates

Filing date:

15/08/2011

Grant date:

10/10/2018

EP Publication Date:

26/06/2013

PCT Publication Date:

23/02/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/10/2018

EP B1 Publication Date:

10/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/08/2019

Expiration date:

15/08/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/10/2018

 

 

Name:

IBC Pharmaceuticals, Inc.

Address:

300 American Road, Morris Plains, NJ 07950, United States (US)

Inventor

1

Name:

GOLDENBERG, David M.

Address:

United States (US)

2

Name:

ROSSI, Edmund A.

Address:

United States (US)

3

Name:

CHANG, Chien-Hsing

Address:

United States (US)

Priority

1

Priority Number:

374449 P

Priority Date:

17/08/2010

Priority Country:

United States (US)

2

Priority Number:

374772 P

Priority Date:

18/08/2010

Priority Country:

United States (US)

3

Priority Number:

374751 P

Priority Date:

18/08/2010

Priority Country:

United States (US)

4

Priority Number:

869823

Priority Date:

27/08/2010

Priority Country:

United States (US)

5

Priority Number:

378059 P

Priority Date:

30/08/2010

Priority Country:

United States (US)

6

Priority Number:

871345

Priority Date:

30/08/2010

Priority Country:

United States (US)

7

Priority Number:

915515

Priority Date:

29/10/2010

Priority Country:

United States (US)

8

Priority Number:

414592 P

Priority Date:

17/11/2010

Priority Country:

United States (US)

9

Priority Number:

949536

Priority Date:

18/11/2010

Priority Country:

United States (US)

10

Priority Number:

964021

Priority Date:

09/12/2010

Priority Country:

United States (US)

11

Priority Number:

968936

Priority Date:

15/12/2010

Priority Country:

United States (US)

12

Priority Number:

201113004349

Priority Date:

11/01/2011

Priority Country:

United States (US)

13

Priority Number:

201113010993

Priority Date:

21/01/2011

Priority Country:

United States (US)

14

Priority Number:

201113012977

Priority Date:

25/01/2011

Priority Country:

United States (US)

15

Priority Number:

201113021302

Priority Date:

04/02/2011

Priority Country:

United States (US)

16

Priority Number:

201113036820

Priority Date:

28/02/2011

Priority Country:

United States (US)

17

Priority Number:

201113086786

Priority Date:

14/04/2011

Priority Country:

United States (US)

18

Priority Number:

201161508871 P

Priority Date:

18/07/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/21; A61K 39/395; A61P 35/00; A61P 37/00; C07K 16/28; C07K 16/30; C07K 16/46;

Publication

European Patent Bulletin

Issue number:

201841

Publication date:

10/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages